1. Home
  2. NKTR vs FLYX Comparison

NKTR vs FLYX Comparison

Compare NKTR & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • FLYX
  • Stock Information
  • Founded
  • NKTR 1990
  • FLYX 2015
  • Country
  • NKTR United States
  • FLYX United States
  • Employees
  • NKTR N/A
  • FLYX N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • FLYX Blank Checks
  • Sector
  • NKTR Health Care
  • FLYX Finance
  • Exchange
  • NKTR Nasdaq
  • FLYX Nasdaq
  • Market Cap
  • NKTR 247.9M
  • FLYX 264.1M
  • IPO Year
  • NKTR 1994
  • FLYX N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • FLYX $3.83
  • Analyst Decision
  • NKTR Strong Buy
  • FLYX Hold
  • Analyst Count
  • NKTR 5
  • FLYX 1
  • Target Price
  • NKTR $4.50
  • FLYX N/A
  • AVG Volume (30 Days)
  • NKTR 3.0M
  • FLYX 46.6K
  • Earning Date
  • NKTR 03-07-2025
  • FLYX 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • FLYX N/A
  • EPS Growth
  • NKTR N/A
  • FLYX N/A
  • EPS
  • NKTR N/A
  • FLYX N/A
  • Revenue
  • NKTR $93,137,000.00
  • FLYX $311,873,000.00
  • Revenue This Year
  • NKTR $12.15
  • FLYX $4.63
  • Revenue Next Year
  • NKTR N/A
  • FLYX $33.97
  • P/E Ratio
  • NKTR N/A
  • FLYX N/A
  • Revenue Growth
  • NKTR 5.53
  • FLYX N/A
  • 52 Week Low
  • NKTR $0.63
  • FLYX $1.79
  • 52 Week High
  • NKTR $1.93
  • FLYX $24.21
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.83
  • FLYX 63.16
  • Support Level
  • NKTR $0.92
  • FLYX $2.73
  • Resistance Level
  • NKTR $1.08
  • FLYX $4.90
  • Average True Range (ATR)
  • NKTR 0.09
  • FLYX 0.53
  • MACD
  • NKTR 0.03
  • FLYX 0.03
  • Stochastic Oscillator
  • NKTR 65.63
  • FLYX 50.78

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: